Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.98 USD
Change Today -1.07 / -4.66%
Volume 1.1M
EXAS On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitleKey Developments
Sally Crawford 86 RelationshipsIndependent Director, Chairperson of Compensation Committee and Member of Audit Committee 
Lionel Sterling 18 RelationshipsIndependent Director and Chairperson of Audit Committee 
Thomas Carey 9 RelationshipsIndependent Director, Member of Compensation Committee and Member of Audit Committee 
Michael Wyzga 56 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitle
Thomas Carey 9 RelationshipsIndependent Director, Member of Compensation Committee and Member of Audit Committee
Sally Crawford 86 RelationshipsIndependent Director, Chairperson of Compensation Committee and Member of Audit Committee
Katherine Napier 16 RelationshipsIndependent Director, Chairperson of Innovation & Technology Committee and Member of Compensation Committee
EXAS Compensation vs. Industry
460.7K
368.1K
Chief Executive Officer
84.6K
263.4K
Chief Financial Officer
338.3K
343.2K
Chief Operating Officer
Share price activity for EXACT SCIENCES CORP (EXAS)
52 Week Price Performance
EXAS
Industry Average

Nominating Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitleKey Developments
David Thompson Ph.D. 9 RelationshipsLead Independent Director and Chairperson of Corporate Governance & Nominating CommitteeExact Sciences Corporation Appoints Michael S. Wyzga as Class III Director
02/10/15
James Doyle 9 RelationshipsDirector, Member of Corporate Governance & Nominating Committee and Member of Innovation & Technology CommitteeExact Sciences Corp. Names Scott Coward as Senior Vice President and General Counsel
01/18/15

Corporate Governance Committee* - exact sciences corp (EXAS)

Name (Connections)Board RelationshipsTitle
James Doyle 9 RelationshipsIndependent Director, Member of Compensation Committee and Member of Audit Committee
David Thompson Ph.D. 9 RelationshipsIndependent Director, Chairperson of Compensation Committee and Member of Audit Committee
EXAS and Competitor
Insiders vs. External
Board
20%
80%
Exact Sciences Corporation
22%
78%
Curis, Inc.
6%
94%
Navidea Biopharmaceuticals, Inc
8%
92%
Delcath Systems, Inc.
14%
86%
Celldex Therapeutics, Inc.
7%
93%
ZIOPHARM Oncology, Inc.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAS:US $21.98 USD -1.07

EXAS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celldex Therapeutics Inc $30.10 USD +0.19
Curis Inc $2.96 USD -0.01
Delcath Systems Inc $1.04 USD 0.00
Navidea Biopharmaceuticals Inc $1.49 USD -0.02
ZIOPHARM Oncology Inc $10.81 USD -0.395
View Industry Companies
 

Industry Analysis

EXAS

Industry Average

Valuation EXAS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,086.5x
Price/Book 7.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 977.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.